nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antiapoptotic BCL-2 is required for maintenance of a model leukemia
|
Letai, Anthony |
|
2004 |
6 |
3 |
p. 241-249 9 p. |
artikel |
2 |
Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2
|
Wang, Shao-Chun |
|
2004 |
6 |
3 |
p. 251-261 11 p. |
artikel |
3 |
Blasts from the past
|
Huntly, Brian J.P. |
|
2004 |
6 |
3 |
p. 199-201 3 p. |
artikel |
4 |
Cancer
|
Hahn, William C. |
|
2004 |
6 |
3 |
p. 215-222 8 p. |
artikel |
5 |
Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands
|
Arap, Marco A. |
|
2004 |
6 |
3 |
p. 275-284 10 p. |
artikel |
6 |
c-Src and cooperating partners in human cancer
|
Ishizawar, Rumey |
|
2004 |
6 |
3 |
p. 209-214 6 p. |
artikel |
7 |
Focus on kidney cancer
|
Linehan, W.Marston |
|
2004 |
6 |
3 |
p. 223-228 6 p. |
artikel |
8 |
High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene
|
Torres-Arzayus, Maria I. |
|
2004 |
6 |
3 |
p. 263-274 12 p. |
artikel |
9 |
Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression
|
Luo, Jun-Li |
|
2004 |
6 |
3 |
p. 297-305 9 p. |
artikel |
10 |
Mouse models of human cancer as tools in drug development
|
Holland, Eric C. |
|
2004 |
6 |
3 |
p. 197-198 2 p. |
artikel |
11 |
Nuclear factor-κB
|
Aggarwal, Bharat B. |
|
2004 |
6 |
3 |
p. 203-208 6 p. |
artikel |
12 |
Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δ
|
Wang, Dingzhi |
|
2004 |
6 |
3 |
p. 285-295 11 p. |
artikel |
13 |
Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1 +/− p53 −/− mice
|
Romer, Justyna T. |
|
2004 |
6 |
3 |
p. 229-240 12 p. |
artikel |